3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
8
INDUSTRY
5
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
2
Other
1
Head & Neck
1
Breast
1
Conditions
Breast Neoplasms
267
Triple Negative Breast Neoplasms
18
Neoplasms
9
Lymphedema
9
Motor Activity
8
Breast Cancer Lymphedema
8
Breast Cancer Female
8
Pathologic Complete Response
6
Neoplasm Metastasis
6
Colorectal Neoplasms
6
Colonic Neoplasms
6
Pain
5
Fatigue
5
Stomach Neoplasms
4
Pain, Postoperative
4
Recurrence
3
Radiodermatitis
3
Hereditary Breast and Ovarian Cancer Syndrome
3
Endometrial Neoplasms
3
Drug-Related Side Effects and Adverse Reactions
3
Breast Diseases
3
Advanced Breast Cancer
3
Treatment Adherence and Compliance
2
Thyroid Neoplasms
2
Seroma
2
Radiation Injuries
2
Ovarian Neoplasms
2
Melanoma
2
Lymphoma
2
Lung Neoplasms
2
Interventions
Morphine
1
Lidocaine
1
Gels
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Cancer Pain
×
Breast
×
Clear all
NCT05800834
2023-09-28
MorphineGEL
Instituto Nacional de Cancer, Brazil
Phase 2
Unknown
106 enrolled